CP-026 Renal safety of tenofovir and cobicistat

BackgroundThe antiretroviral combination tenofovir disoproxil, emtricitabine, cobicistat and elvitegravir (TDF/FTC/COBI/RVG) has been widely used to treat HIV infection. This regimen is related to the highest risk of kidney disease because of the ability of cobicistat to block creatinine tubular sec...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2017-03, Vol.24 (Suppl 1), p.A11-A11
Hauptverfasser:	Mangas, C Meneses, Comas, R Medina, Morera, D Briegas, Lobato, E Garcia, Galán, C Bonilla, Clavo, S Martin, Mayoral, JF Rangel, García-Cuevas, L Bravo, Gudiño, Y Gonzalez
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral drugs Creatinine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!